Evidence map›Paper›PMID 37878335›Full record

ArticleFASEB journal : official publication of the Federation of American Societies for Experimental Biology2023

The ketone body β-hydroxybutyrate shifts microglial metabolism and suppresses amyloid-β oligomer-induced inflammation in human microglia.

Lee-Way Jin, Jacopo Di Lucente, Ulises Ruiz Mendiola, Nopparat Suthprasertporn, Alexey Tomilov, Gino Cortopassi, Kyoungmi Kim, Jon J Ramsey, Izumi Maezawa

Open access · greenAbstract read
In one paragraph

Article in FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
7.4field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 42 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Article
  5. Article
  6. β-Hydroxybutyrate Exposure is Associated with Increased THCellular and molecular neurobiology · 2026
    Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Cell type-specific master metabolic regulators of Alzheimer's disease.bioRxiv : the preprint server for biology · 2025
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Lee-Way JinDepartment of Pathology and Laboratory Medicine and Medical Investigation of Neurodevelopmental Disorders, University of California Davis Medical Center, Sacramento, California, USA.ORCID 0000-0001-9729-1032
Jacopo Di LucenteDepartment of Pathology and Laboratory Medicine and Medical Investigation of Neurodevelopmental Disorders, University of California Davis Medical Center, Sacramento, California, USA.ORCID 0000-0001-5312-5542
Ulises Ruiz MendiolaDepartment of Pathology and Laboratory Medicine and Medical Investigation of Neurodevelopmental Disorders, University of California Davis Medical Center, Sacramento, California, USA.ORCID 0000-0002-7429-3614
Nopparat SuthprasertpornDepartment of Pathology and Laboratory Medicine and Medical Investigation of Neurodevelopmental Disorders, University of California Davis Medical Center, Sacramento, California, USA.ORCID 0000-0002-2204-8908
Alexey TomilovDepartment of Molecular Biosciences, University of California, Davis, Davis, California, USA.ORCID 0000-0002-7025-6197
Gino CortopassiDepartment of Molecular Biosciences, University of California, Davis, Davis, California, USA.ORCID 0000-0003-2563-4133
Kyoungmi KimMedical Investigation of Neurodevelopmental Disorders Institute, University of California Davis Medical Center, Sacramento, California, USA.ORCID 0000-0002-8661-7508
Jon J RamseyDepartment of Molecular Biosciences, University of California, Davis, Davis, California, USA.ORCID 0000-0003-1927-5365
Izumi MaezawaDepartment of Pathology and Laboratory Medicine and Medical Investigation of Neurodevelopmental Disorders, University of California Davis Medical Center, Sacramento, California, USA.ORCID 0000-0002-8666-3520
University of California Davis Medical Center · USUniversity of California, Davis · US

Funding

UC Davis Alzheimer's Disease Research CenterP30AG072972 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI Charles DeCarli, Rachel A Whitmer · 2021 to 2026
$25.2M
TRANSLOCATION OF p66Shc: KINETICS, FUNCTION, APOPTOSISP01AG025532 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KIM, KYOUNGMI · 2007 to 2017
$12.1M
Research Project: Pathologic Significance of Maternal AutoantibodiesP50HD103526 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI LEONARD J. ABBEDUTO, Melissa Dawn Bauman · 2020 to 2026
$9.7M
Soluble epoxide hydrolase-regulated lipid signaling in Alzheimer’s diseaseRF1AG071665 · NIA · UNIVERSITY OF CALIFORNIA AT DAVIS · PI JIN, LEE-WAY, MAEZAWA, IZUMI · 2021 to 2021
$1.9M
NIA NIH HHS P01 AG025532NIA NIH HHS P30 AG072972NIA NIH HHS RF1 AG071665NICHD NIH HHS P50 HD103526
6 · The paper itself

Abstract

Fatty acids are metabolized by β-oxidation within the "mitochondrial ketogenic pathway" (MKP) to generate β-hydroxybutyrate (BHB), a ketone body. BHB can be generated by most cells but largely by hepatocytes following exercise, fasting, or ketogenic diet consumption. BHB has been shown to modulate systemic and brain inflammation; however, its direct effects on microglia have been little studied. We investigated the impact of BHB on Aβ oligomer (AβO)-stimulated human iPS-derived microglia (hiMG), a model relevant to the pathogenesis of Alzheimer's disease (AD). HiMG responded to AβO with proinflammatory activation, which was mitigated by BHB at physiological concentrations of 0.1-2 mM. AβO stimulated glycolytic transcripts, suppressed genes in the β-oxidation pathway, and induced over-expression of AD-relevant p46Shc, an endogenous inhibitor of thiolase, actions that are expected to suppress MKP. AβO also triggered mitochondrial Ca

Indexed as

Alzheimer DiseaseMicroglia3-Hydroxybutyric AcidAmyloid beta-PeptidesAnimalsHumansInflammationKetone BodiesMice3-Hydroxybutyric AcidAmyloid beta-PeptidesKetone BodiesAlzheimer'samyloidinflammationketonemicrogliamitochondriaphagocytosis

Identifiers

PMID37878335
PMCPMC11892113
OpenAlexW4387930874

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.